Journals / Haydarpaşa Numune Medical Journal / 2021 / Cilt: 61 - Sayı: 3

Pulmonary Findings in Rheumatic Diseases

Pages
289–294
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It leads to correct diagnosis and treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: One of the affected systems in rheumatic diseases is the respiratory system.
📊
Key Findings & Data:Methods: Rheumatic patients, who were requested consultation by the Bağcılar Training and Research Hospital Training and Research Hospital Department of Chest Diseases between 2015 and 2017, have been included in the study.
💡
Conclusion & Impact:It leads to correct diagnosis and treatment.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: One of the affected systems in rheumatic diseases is the respiratory system. This study was carried out to investigate the pulmonary involvement findings and the respiratory function tests in rheumatic diseases. Methods: Rheumatic patients, who were requested consultation by the Bağcılar Training and Research Hospital Training and Research Hospital Department of Chest Diseases between 2015 and 2017, have been included in the study. A total of 110 patients; 64 rheumatoid arthritis, 43 ankylosing spondylitis, two psoriatic arthritis, and one Behcet were included in the study. Pulmonary involvement findings, respiratory examination findings, and pulmonary function tests (RFT) in chest X-ray and high-resolution computed tomography (HRCT) were examined. Results: About 33.64% normal and 66.36% abnormal findings were observed in HRCT findings. Abnormal HRCT findings were found in 70% of RA patients (n=45) and in 58% of patients with AS (n=25). When RFTs were examined, 50.0% normal, 32.7% restrictive type respiratory disorder, 15.5% mixed type respiratory disorder, and 1.8% obstructive respiratory disorder were observed. Discussion and Conclusion: Pulmonary involvement with rheumatic diseases can be seen in different ways. HRCT and RFT provide information on the prevalence and grade of pulmonary disease. It leads to correct diagnosis and treatment.

🔖

Cite This Article

ÖZGÜL, G., ÜSTÜN, I. (2022). Pulmonary Findings in Rheumatic Diseases. Haydarpaşa Numune Medical Journal, Cilt: 61 - Sayı: 3, 289–294. https://ajindex.com/articles/535918

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ha YJ, Lee YJ, Kang EH. Lung involvements in rheumatic dis- eases: Update on the epidemiology, pathogenesis, clinical features, and treatment. Biomed Res Int 2018;2018:6930297
  2. Tekeoğlu İ, Hız Ö, Özbay B, Toprak M. Sistemik romatizmal hastaliklarda akciğer tutulumu: HRCT bulgulari. J Clin Anal Med 2011;2:36–9
  3. Carrera LG, Hernan GB. Pulmonary manifestations of collagen diseases. Arch Bronconeumol 2013;49:249–60
  4. Mayberry JP, Primack SL, Müller NL. Thoracic manifestations of systemic autoimmune diseases: Radiographic and high-reso- lution CT findings. Radiographics 2000;20:1623–35
  5. Wellsand AU, Denton CP. Interstitial lung disease in connec- tive tissue disease-mechanisms and management. Nat Rev Rheumatol 2014;10:728–39
  6. Alunno A, Gerli R, Giacomelli R, Carubbi F. Clinical, epi- demiological, and histopathological features of respira- tory involvement in rheumatoid arthritis. Biomed Res Int 2017;2017:7915340
  7. Myasoedova E, Crowson CS, Turesson C, Gabriel SE, Matteson EL. Incidence of extraarticular rheumatoidarthritis in Olmst - edCounty, Minnesota, in 1995-2007 versus 1985-1994: A pop- ulation-basedstudy. J Rheumatol 2011;38:983–9
  8. Carloni A, Piciucchi S, Giannakakis K, Nori G, Zobel BB, Po-letti V. Diffuse alveolar hemorrhage after leflunomide ther - apy in a patient with rheumatoid arthritis. J Thorac Imaging 2008;23:57–9
  9. Kiris A, Ozgocmen S, Kocakoc E, Ardicoglu O, Ogur E. Lung findings on highresolution CT in early ankylosing spondylitis. Eur J Radiol 2003;47:71–6
  10. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Pulmonary manifestations of systemic autoimmune diseases. Maedica (Buchar) 2011;6:224–9
  11. Bilgin G, Sungur G, Kucukterzi V. Systemic and pulmonary screening of patients with Behçet's disease during periodic follow-up. Respir Med 2013;107:466–71
  12. Rodrigues CE, Vieira WP, Bortoluzzo AB, Gonçalves CR, da Silva JA, et al. Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondy- loarthritis: Analysis of the Brazilian registry of spondyloarthri- tis. Rev Bras Reumatol 2012;52:375–83
  13. Kelly C, Iqbal K, Iman-Gutierrez L, Evans P, Manchegowda K. Lung involvement in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 2016;30:870–88
  14. Quismorio FP Jr. Pulmonary involvoment in ankylosing spondylitis. Curr Opin Pulm Med 2006;12:342–5
  15. Ayhan-Ardic FF, OkenO, Yorgancıoğlu ZR, Ustun N. Pulmonary involvoment in lifelong non-smoking patients with rh